tradingkey.logo
tradingkey.logo
Search

Corcept Therapeutics Inc

CORT
Add to Watchlist
114.490USD
-3.830-3.24%
Close 07-31 16:00ETQuotes delayed by 15 min
12.38BMarket Cap
249.99P/E TTM

Institutional Confidence

Currency: USD Updated: 2026-07-31
Previous score
7.00
Change
0
The current institutional shareholding score of Corcept Therapeutics Inc is 7.00, ranking 50 out of 155 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 71.62%, representing a quarter-over-quarter decrease of 14.25%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 5.29% of shares outstanding, with 0.07% decrease in holdings.

Institutional Shareholding

Shareholder Activity

Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
11.05M
+1.03%
Ingalls & Snyder LLC (Asset Management)
7.20M
-6.53%
Renaissance Technologies LLC
Star Investors
5.76M
-5.43%
Baker (George Leonard Jr.)
5.41M
+1.88%
Parallel Advisors, LLC
3.88M
+0.20%
State Street Investment Management (US)
2.99M
+0.53%
Belanoff (Joseph K)
2.98M
--
Geode Capital Management, L.L.C.
2.67M
+37.98%
1
2
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.